Report Detail
Ventricular Assist Devices (VAD) Global Market
- RnM2895582 |
- 12 March, 2020 |
- Global |
- 276 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The ventricular assist devices (VAD) are used to treat end stage heart failure. The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body.
Products of Ventricular assist devices market is segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD). VAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. VAD market by implant type is segmented into Extracorporeal VAD, Intracorporeal VAD and Percutaneous VAD. VAD market by patient type is segmented into Adult and Pediatric VAD. Applications of Ventricular assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR).
This report concentrates on ventricular assist devices that are placed internally or externally for treating end stage heart failure. The other mechanical circulatory devices like Total artificial heart (TAH), Extracorporeal membrane oxygenation (ECMO) and Intra-aortic balloon pump (IABP) are not considered in Ventricular assist devices report.
The Ventricular assist devices global market is expected to grow at double digit CAGR to reach $2,850.1 million by 2023. Among the Ventricular assist devices products, the Left ventricular assist device market dominated the products market by occupying a largest share in 2016 and the percutaneous VAD market is the fastest growing segment during the forecasting period. In applications, Bridge to Transplantation is the largest segment and Bridge to Recovery is the fastest growing segment.
Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is the fastest growing region with double digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the ventricular assist devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
The Ventricular assist devicesis expected to grow at a strong CAGR during 2016 to 2023. Increasing incidences of cardiovascular diseases due to change in lifestyle, shortage of donor heart, Rise in the number of heart failure, shortage of donor heart, increasing ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the ventricular assist devices global market. Many entry level barriers, stringent regulations, high cost of the device, adverse events due to VAD implant and lack of skilled and trained professionals are some of the factors hampering the growth of Ventricular assist devices market.
The ventricular assist devices global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Ventricular assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Berlin Heart GmbH (Germany), EvaHeart (U.S.), Jarvik Heart (U.S.), Reliant Heart (U.S.), TandemLife (U.S.), etc.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Others
• Europe
o Germany
o France
o U.K.
o Others
• Asia-Pacific
o Japan
o China
o India
o Others
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East and others
1 EXECUTIVE SUMMARY 19
2 INTRODUCTION 24
- 2.1 KEY TAKEAWAYS 24
- 2.2 REPORT DESCRIPTION 25
- 2.3 MARKETS COVERED 27
- 2.4 STAKEHOLDERS 28
- 2.5 RESEARCH METHODOLOGY 29
- 2.5.1 MARKET SIZE ESTIMATION 30
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 33
- 2.5.3 SECONDARY SOURCES 34
- 2.5.4 PRIMARY SOURCES 35
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 35
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 36
- 2.5.7 ASSUMPTIONS 36
3 MARKET ANALYSIS 38
- 3.1 INTRODUCTION 38
- 3.2 MARKET SEGMENTATION 39
- 3.3 FACTORS INFLUENCING MARKET 41
- 3.3.1 DRIVERS AND OPPORTUNITIES 42
- 3.3.1.1 Increase incidence of heart failure 42
- 3.3.1.2 Shortage of heart donors 43
- 3.3.1.3 Technological advancements in VAD 44
- 3.3.1.4 Rising geriatric population 45
- 3.3.1.5 Vast pipeline products 45
- 3.3.1.6 Expansion of LVAD centres in emerging countries 46
- 3.3.1.7 New product launches 46
- 3.3.1.8 Increase in funding for LVAD research 47
- 3.3.2 RESTRAINTS AND THREATS 48
- 3.3.2.1 Adverse events and complication with the implantations of VAD 48
- 3.3.2.2 Cost of the devices 49
- 3.3.2.3 Stringent regulatory guidelines 49
- 3.3.2.4 Lack of skilled and trained professionals 50
- 3.3.2.5 Availability of alternative products 51
- 3.3.2.6 Reimbursement issues in emerging countries 51
- 3.3.1 DRIVERS AND OPPORTUNITIES 42
- 3.4 REGULATORY AFFAIRS 52
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 52
- 3.4.2 U.S. 53
- 3.4.3 CANADA 54
- 3.4.4 EUROPE 55
- 3.4.5 CHINA 56
- 3.4.6 JAPAN 57
- 3.4.7 INDIA 58
- 3.5 REIMBURSEMENT SCENARIO 60
- 3.5.1 REIMBURSEMENT TABLE 61
- 3.5.1.1 Ventricular assist device reimbursement 61
- 3.5.1.2 VAD physician reimbursement 61
- 3.5.1 REIMBURSEMENT TABLE 61
- 3.6 CLINICL TRIAL DATA 64
- 3.7 PATENT TRENDS 66
- 3.8 TECHNOLOGICAL ADVANCEMENTS 68
- 3.8.1 INTRODUCTION 68
- 3.8.2 WIRELESS HEART PUMP 68
- 3.8.3 MINIATURIZATION OF IMPLANTABLE VENTRICULAR ASSIST DEVICES 69
- 3.8.4 VAD APPLICATION 69
- 3.8.5 SUPPORTING TOOLS FOR LVAD IMPLANTATION 70
- 3.8.6 PERCUTANEOUS VENTRICULAR ASSIST DEVICES 70
- 3.9 PORTER’S FIVE FORCE ANALYSIS 72
- 3.9.1 THREAT OF NEW ENTRANTS 73
- 3.9.2 THREAT OF SUBSTITUTES 73
- 3.9.3 BARGAINING POWER OF SUPPLIERS 74
- 3.9.4 BARGAINING POWER OF BUYERS 74
- 3.9.5 COMPETITIVE RIVALRY 75
- 3.10 SUPPLY CHAIN ANALYSIS 76
- 3.11 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 80
- 3.12 VENTRICULAR ASSIST DEVICES NUMBER OF UNITS BY REGION 82
- 3.12.1 EXTRACORPOREAL VENTRICULAR ASSIST DEVICES 83
- 3.12.2 INTRACORPOREAL VENTRICULAR ASSIST DEVICES 85
- 3.12.3 PERCUTANEOUS VENTRICULAR ASSIST DEVICES 87
- 3.13 COMPARISON OF VENTRICULAR ASSIST DEVICES 88
4 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PRODUCT 89
- 4.1 INTRODUCTION 89
- 4.2 LEFT VENTRICULAR ASSIST DEVICES (LVAD) 92
- 4.3 RIGHT VENTRICULAR ASSIST DEVICES (RVAD) 95
- 4.4 BI-VENTRICULAR ASSIST DEVICES (BIVAD) 98
5 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE 101
- 5.1 INTRODUCTION 101
- 5.2 EXTRACORPOREAL VAD 104
- 5.3 INTRACORPOREAL VAD 107
- 5.4 PERCUTANEOUS VAD 110
6 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE 113
- 6.1 INTRODUCTION 113
- 6.2 PULSATILE FLOW PUMP 116
- 6.3 CONTINUOUS FLOW PUMP 118
- 6.3.1 CENTRIFUGAL FLOW PUMP 121
- 6.3.2 AXIAL FLOW PUMP 122
7 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE 123
- 7.1 INTRODUCTION 123
- 7.2 PEDIATRIC VAD 126
- 7.3 ADULT VAD 129
8 VENTRICULAR ASSIST DEVICES GLOBAL MARKET, BY APPLICATION 132
- 8.1 INTRODUCTION 132
- 8.2 BRIDGE TO TRANSPLANT (BTT) 135
- 8.3 BRIDGE TO DESTINATION THERAPY (BTD) 138
- 8.4 BRIDGE TO RECOVERY (BTR) 141
9 REGIONAL ANALYSIS 144
- 9.1 INTRODUCTION 144
- 9.2 NORTH AMERICA 147
- 9.2.1 U.S. 156
- 9.2.2 OTHERS 160
- 9.3 EUROPE 163
- 9.3.1 GERMANY 172
- 9.3.2 FRANCE 175
- 9.3.3 U.K. 178
- 9.3.4 OTHERS 181
- 9.4 APAC 184
- 9.4.1 JAPAN 193
- 9.4.2 CHINA 196
- 9.4.3 INDIA 199
- 9.4.4 OTHERS 202
- 9.5 ROW 205
- 9.5.1 BRAZIL 213
- 9.5.2 REST OF LATIN AMERICA 216
- 9.5.3 MIDDLE EAST AND OTHERS 219
10 COMPANY DEVELOPMENTS 222
- 10.1 INTRODUCTION 222
- 10.2 APPROVALS 223
- 10.3 ACQUISITIONS 226
- 10.4 PARTNERSHIPS 228
- 10.5 OTHER DEVELOPMENTS 229
11 MAJOR COMPANIES 231
- 11.1 ABBOTT LABORATORIES 231
- 11.1.1 OVERVIEW 231
- 11.1.2 FINANCIALS 232
- 11.1.3 PRODUCT PORTFOLIO 235
- 11.1.4 KEY DEVELOPMENTS 235
- 11.1.5 BUSINESS STRATEGY 237
- 11.1.6 SWOT ANALYSIS 238
- 11.2 ABIOMED, INC. 239
- 11.2.1 OVERVIEW 239
- 11.2.2 FINANCIALS 240
- 11.2.3 PRODUCT PORTFOLIO 242
- 11.2.4 KEY DEVELOPMENTS 242
- 11.2.5 BUSINESS STRATEGY 244
- 11.2.6 SWOT ANALYSIS 245
- 11.3 BERLIN HEART GMBH 246
- 11.3.1 OVERVIEW 246
- 11.3.2 FINANCIALS 247
- 11.3.3 PRODUCT PORTFOLIO 247
- 11.3.4 KEY DEVELOPMENTS 247
- 11.3.5 BUSINESS STRATEGY 247
- 11.3.6 SWOT ANALYSIS 248
- 11.4 EVAHEART, INC. 249
- 11.4.1 OVERVIEW 249
- 11.4.2 FINANCIALS 249
- 11.4.3 PRODUCT PORTFOLIO 249
- 11.4.4 KEY DEVELOPMENTS 249
- 11.4.5 BUSINESS STRATEGY 250
- 11.4.6 SWOT ANALYSIS 251
- 11.5 FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG) 252
- 11.5.1 OVERVIEW 252
- 11.5.2 FINANCIALS 253
- 11.5.3 PRODUCT PORTFOLIO 255
- 11.5.4 KEY DEVELOPMNTS 256
- 11.5.5 BUSINESS STRATEGY 256
- 11.5.6 SWOT ANALYSIS 257
- 11.6 JARVIK HEART INC. 258
- 11.6.1 OVERVIEW 258
- 11.6.2 FINANCIALS 258
- 11.6.3 PRODUCT PORTFOLIO 258
- 11.6.4 KEY DEVELOPMNTS 259
- 11.6.5 BUSINESS STRATEGY 259
- 11.6.6 SWOT ANALYSIS 260
- 11.7 MEDTRONIC PLC 261
- 11.7.1 OVERVIEW 261
- 11.7.2 FINANCIALS 262
- 11.7.3 PRODUCT PORTFOLIO 266
- 11.7.4 KEY DEVELOPMENTS 266
- 11.7.5 BUSINESS STRATEGY 267
- 11.7.6 SWOT ANALYSIS 268
- 11.8 RELIANTHEART INC. 269
- 11.8.1 OVERVIEW 269
- 11.8.2 FINANCIALS 269
- 11.8.3 PRODUCT PORTFOLIO 269
- 11.8.4 KEY DEVELOPMNTS 270
- 11.8.5 BUSINESS STRATEGY 271
- 11.8.6 SWOT ANALYSIS 272
- 11.9 TANDEMLIFE 273
- 11.9.1 OVERVIEW 273
- 11.9.2 FINANCIALS 273
- 11.9.3 PRODUCT PORTFOLIO 273
- 11.9.4 KEY DEVELOPMNTS 274
- 11.9.5 BUSINESS STRATEGY 274
Summary:
Get latest Market Research Reports on Ventricular Assist Devices (VAD) . Industry analysis & Market Report on Ventricular Assist Devices (VAD) is a syndicated market report, published as Ventricular Assist Devices (VAD) Global Market . It is complete Research Study and Industry Analysis of Ventricular Assist Devices (VAD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
